Waś, J.; Gawor-Prokopczyk, M.; Sioma, A.; Szewczyk, R.; Pel, A.; Krzysztoń-Russjan, J.; Niedolistek, M.; Sokołowska, D.; Grzybowski, J.; Mazurkiewicz, Ł.
Proteomic Analysis of Serum in Cardiac Transthyretin Amyloidosis: Diagnostic and Prognostic Implications for Biomarker Discovery. Biomedicines 2025, 13, 1647.
https://doi.org/10.3390/biomedicines13071647
AMA Style
Waś J, Gawor-Prokopczyk M, Sioma A, Szewczyk R, Pel A, Krzysztoń-Russjan J, Niedolistek M, Sokołowska D, Grzybowski J, Mazurkiewicz Ł.
Proteomic Analysis of Serum in Cardiac Transthyretin Amyloidosis: Diagnostic and Prognostic Implications for Biomarker Discovery. Biomedicines. 2025; 13(7):1647.
https://doi.org/10.3390/biomedicines13071647
Chicago/Turabian Style
Waś, Joanna, Monika Gawor-Prokopczyk, Agnieszka Sioma, Rafał Szewczyk, Aleksandra Pel, Jolanta Krzysztoń-Russjan, Magdalena Niedolistek, Dorota Sokołowska, Jacek Grzybowski, and Łukasz Mazurkiewicz.
2025. "Proteomic Analysis of Serum in Cardiac Transthyretin Amyloidosis: Diagnostic and Prognostic Implications for Biomarker Discovery" Biomedicines 13, no. 7: 1647.
https://doi.org/10.3390/biomedicines13071647
APA Style
Waś, J., Gawor-Prokopczyk, M., Sioma, A., Szewczyk, R., Pel, A., Krzysztoń-Russjan, J., Niedolistek, M., Sokołowska, D., Grzybowski, J., & Mazurkiewicz, Ł.
(2025). Proteomic Analysis of Serum in Cardiac Transthyretin Amyloidosis: Diagnostic and Prognostic Implications for Biomarker Discovery. Biomedicines, 13(7), 1647.
https://doi.org/10.3390/biomedicines13071647
